Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Snyder

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nuclear Medicine and Biology|December 24, 1998
Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activityS E Snyder, L Tluczek, D M Jewett, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 12, 2001
Dual-[11C]tracer single-acquisition positron emission tomography studiesR A Koeppe, D M Raffel, S E Snyder, et al.
Journal of Medicinal Chemistry|November 23, 2000
Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptorsM B Skaddan, M R Kilbourn, S E Snyder, et al.
Neuroscience|March 4, 1998
The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesionS E Snyder, H W Cheng, K D Murray, et al.
Journal of Medicinal Chemistry|June 23, 1995
Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamineS E Snyder, F A Aviles-Garay, R Chakraborti, et al.
Frontiers in Neuroendocrinology|July 7, 2000
VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balanceS R Salton, G L Ferri, S Hahm, et al.
Brain Research. Molecular Brain Research|September 11, 1992
Expression of human mid-sized neurofilament subunit in transgenic miceV M Lee, G A Elder, L C Chen, et al.
Neurology|March 17, 1999
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's diseaseD E Kuhl, R A Koeppe, S Minoshima, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 15, 2001
Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activityS E Snyder, N Gunupudi, P S Sherman, et al.
Journal of Medicinal Chemistry|July 7, 1995
Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxidesS E Snyder, A Kume, Y W Jung, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nuclear Medicine and Biology|December 24, 1998
Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activityS E Snyder, L Tluczek, D M Jewett, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 12, 2001
Dual-[11C]tracer single-acquisition positron emission tomography studiesR A Koeppe, D M Raffel, S E Snyder, et al.
Journal of Medicinal Chemistry|November 23, 2000
Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptorsM B Skaddan, M R Kilbourn, S E Snyder, et al.
Neuroscience|March 4, 1998
The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesionS E Snyder, H W Cheng, K D Murray, et al.
Journal of Medicinal Chemistry|June 23, 1995
Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamineS E Snyder, F A Aviles-Garay, R Chakraborti, et al.
Frontiers in Neuroendocrinology|July 7, 2000
VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balanceS R Salton, G L Ferri, S Hahm, et al.
Brain Research. Molecular Brain Research|September 11, 1992
Expression of human mid-sized neurofilament subunit in transgenic miceV M Lee, G A Elder, L C Chen, et al.
Neurology|March 17, 1999
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's diseaseD E Kuhl, R A Koeppe, S Minoshima, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 15, 2001
Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activityS E Snyder, N Gunupudi, P S Sherman, et al.
Journal of Medicinal Chemistry|July 7, 1995
Synthesis of carbon-11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3-dithianes and -dithiane oxidesS E Snyder, A Kume, Y W Jung, et al.
Pageof 4